Cite Filings / EDIT / 0001650664-26-000103
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

Editas Medicine, Inc. · Filed 2026-11-09 · Acc 0001650664-26-000103

Documents 1

  • 10-Q Quarterly Report , edit-20260930.htm

Around this filing

  • 2026-11-13 4 CEO sold 21,164 shares at $2.42 ($51,122)
  • 2026-11-13 4 EVP, CHIEF SCIENTIFIC OFFICER sold 7,814 shares at $2.42 ($18,875)
  • 2026-11-09 10-Q Quarterly Report
  • 2026-11-09 8-K Results of operations
  • 2026-11-06 4 EVP, CHIEF SCIENTIFIC OFFICER acquired 16,533 shares (grant or award)
  • 2026-11-06 4 CEO acquired 43,567 shares (grant or award)
  • 2026-08-05 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading edit-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…